Amneal Pharmaceuticals(DE:2DT)
€19.30+0.60 (+3.21%)
DE:2DT
Amneal Pharmaceuticals ownership
€19.30
At close:+0.60 (+3.21%)
Amneal Pharmaceuticals (2DT) Ownership - Who Owns Amneal Pharmaceuticals?
2 Followers
Amneal Pharmaceuticals (2DT) Ownership Overview
- 36.76% Insiders
- 11.00% Mutual Funds
- 19.12% Other Institutional Investors
- 16.37% ETFs
- 16.75% Public Companies and Individual Investors
The ownership structure of Amneal Pharmaceuticals (DE:2DT) stock is a mix of institutional, retail, and individual investors. Approximately 46.49% of the company’s stock is owned by Institutional Investors, 36.76% is owned by Insiders, and 16.75% is owned by Public Companies and Individual Investors.
Institutional holdings as of
The ownership structure of Amneal Pharmaceuticals (DE:2DT) stock is a mix of institutional, retail, and individual investors. Approximately 46.49% of the company’s stock is owned by Institutional Investors, 36.76% is owned by Insiders, and 16.75% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 13, 2026 | John Kiely | $882,000 | |
| Aug 12, 2026 | Nikita Shah | $2,563,517 | |
| Aug 12, 2026 | Jason B. Daly | $3,771,050 | |
| May 11, 2026 | Deborah M. Autor | $450,558 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Graham Capital Management, L.p. | €1,139,342 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Tushar Bhikhubhai Patel | 61,341,678 | Insider | 17.61% | 1,299,032,715 |
| Chintu Patel | 32,523,507 | Insider | 9.33% | 688,750,308 |
| Chirag K. Patel | 29,044,624 | Insider | 8.34% | 615,078,002 |
| BlackRock, Inc. | 26,877,188 | Institution | 7.71% | 569,178,210 |
| Ishares | 20,708,543 | Institution | 5.94% | 438,544,815 |
| Vanguard | 15,678,893 | Institution | 4.50% | 332,031,917 |
| Vanguard Index Funds | 14,107,729 | Institution | 4.05% | 298,759,377 |
| Invesco | 4,430,102 | Institution | 1.27% | 93,816,270 |
| Spdr | 3,931,505 | Institution | 1.13% | 83,257,481 |
| Dfa | 3,528,989 | Institution | 1.01% | 74,733,400 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 14,107,729 | Institution | 4.05% | 298,759,377 |
| Dfa Investment Dimensions Group Inc | 2,842,778 | Institution | 0.82% | 60,201,510 |
| Tiaa-cref Funds | 2,125,064 | Institution | 0.61% | 45,002,480 |
| Fidelity Salem Street Trust | 2,107,263 | Institution | 0.60% | 44,625,509 |
| Neuberger Berman Equity Funds | 1,908,642 | Institution | 0.55% | 40,419,312 |
| Fidelity Concord Street Trust | 1,805,575 | Institution | 0.52% | 38,236,662 |
| Vanguard Scottsdale Funds | 1,159,829 | Institution | 0.33% | 24,561,699 |
| Columbia Funds Series Trust | 1,121,364 | Institution | 0.32% | 23,747,125 |
| Vanguard Horizon Funds | 1,106,769 | Institution | 0.32% | 23,438,047 |
| Vanguard Explorer Fund | 880,942 | Institution | 0.25% | 18,655,709 |
FAQ
Who Owns Amneal Pharmaceuticals (DE:2DT)?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 46.49% of the company's stock is held by institutional investors, 36.76% is held by insiders, and 16.75% is held by public companies and individual investors.
What percentage of Amneal Pharmaceuticals (DE:2DT) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 46.49% of Amneal Pharmaceuticals (DE:2DT) stock is held by institutional investors: 11.00% by mutual funds, 16.37% by ETFs and 19.12% by other institutional investors.
What percentage of Amneal Pharmaceuticals (DE:2DT) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 16.75% of Amneal Pharmaceuticals (DE:2DT) stock is held by public companies and individual investors.
Who owns the most shares of Amneal Pharmaceuticals (DE:2DT)?
Tushar Bhikhubhai Patel owns the most shares of Amneal Pharmaceuticals (DE:2DT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

